A myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease progression.

KALAMAZOO, Mich. — A charity hockey game is on the way to Western Michigan University's (WMU) Lawson Ice Arena this spring.

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...

A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...